Drug Discovery Stocks List

Recent Signals

Date Stock Signal Type
2019-09-13 ABVC 20 DMA Support Bullish
2019-09-13 AMBS Crossed Above 20 DMA Bullish
2019-09-13 AMBS Crossed Above 50 DMA Bullish
2019-09-13 AMBS MACD Bullish Centerline Cross Bullish
2019-09-13 AMBS MACD Bullish Signal Line Cross Bullish
2019-09-13 AMBS Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-13 BIMUF Narrow Range Bar Range Contraction
2019-09-13 BIMUF Fell Below 20 DMA Bearish
2019-09-13 BNOEF MACD Bullish Signal Line Cross Bullish
2019-09-13 BNOEF Narrow Range Bar Range Contraction
2019-09-13 BNOEF Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-13 DTRK Fell Below 50 DMA Bearish
2019-09-13 DTRK NR7 Range Contraction
2019-09-13 DTRK Narrow Range Bar Range Contraction
2019-09-13 DTRK MACD Bearish Centerline Cross Bearish
2019-09-13 DTRK 180 Bearish Setup Bearish Swing Setup
2019-09-13 LIXT MACD Bearish Signal Line Cross Bearish
2019-09-13 LIXT Narrow Range Bar Range Contraction
2019-09-13 NPHC Pocket Pivot Bullish Swing Setup
2019-09-13 NPHC Narrow Range Bar Range Contraction
2019-09-13 NPHC Crossed Above 200 DMA Bullish
2019-09-13 NPHC Crossed Above 50 DMA Bullish
2019-09-13 NPHC Crossed Above 20 DMA Bullish
2019-09-13 PBIO Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-13 PBIO Fell Below 200 DMA Bearish
2019-09-13 PFSCF Narrow Range Bar Range Contraction
2019-09-13 PFSCF Crossed Above 20 DMA Bullish
2019-09-13 PFSCF Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2019-09-13 PPCB Narrow Range Bar Range Contraction
2019-09-13 PPCB Stochastic Buy Signal Bullish
2019-09-13 RCPIQ Narrow Range Bar Range Contraction
2019-09-13 RCPIQ Doji - Bearish? Reversal
2019-09-13 RCPIQ Bollinger Band Squeeze Range Contraction
2019-09-13 RCPIQ Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2019-09-13 RCPIQ 50 DMA Support Bullish
2019-09-13 SGIOY Lizard Bearish Bearish Day Trade Setup
2019-09-13 SGIOY Bollinger Band Squeeze Range Contraction
2019-09-13 SGIOY Doji - Bearish? Reversal
2019-09-13 SGIOY Shooting Star Candlestick Bearish
2019-09-13 SOAN Narrow Range Bar Range Contraction
2019-09-13 SOAN Stochastic Reached Oversold Weakness
2019-09-13 SOAN Spinning Top Other

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as
classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.
Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, "expensive, difficult, and inefficient process" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity was about US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The "final product" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.
Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.

More about Drug Discovery